▲ Up
 
23:03 30-01-2015
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
17:35 No universal calculation parameters for comparison of shadow economies of different countries exist – President’s Administration17:21 Economy Ministry proposes to adopt list of goods to be exported and imported under license17:19 Tajikistan, WB discuss prospects of cooperation in agricultural sector17:12 10 of 22 MP candidates fail Tajik language test17:02 Uzbekistan takes part in food festival in India16:58 Kids in one of children institutions claim they were photographed naked in shower and toilet: expert16:32 Balloonists surpass world distance record16:31 Kazakhstan to allocate $325.3 million for spring sowing campaign in 201516:22 UNISDR ready to assist Kyrgyz Ministry of Emergency Situations - Fengmin Kan16:16 Kyrgyz delegation to PACE winter session in France meets with parliamentary delegations of several countries16:14 Tajik FM, Chairman of OSCE Office in Dushanbe discuss cooperation issues16:06 Kazakh language to switch to Roman alphabet - Ministry15:58 Tajik border law enforcement agencies complete risk analysis, profiling and management training course15:57 World Bank to allocate Kyrgyzstan $24 million to provide electricity to remote and less developed areas15:53 UNHCR aims at ending statelessness worldwide by end-202415:43 HRW report voices concern over rights violations15:40 New Saudi King announces major government shake-up15:35 Islam Karimov turns 77 today15:32 Kyrgyz Ambassador, International Islamic Charitable Organization discuss human development project implementation15:24 Japan to invest $38 billion in Uzbekistan
Astana
-12° C
Ashgabat
+9° C
Bishkek
-1° C
Dushanbe
+8° C
Tashkent
+4° C
exchange rates
 
67.52
59.81
9.62
0.87
208.19
184.45
29.54
2.67
6.05
5.37
0.86
0.08
2830.23
2436.16
389.63
38.43
3.96
3.50
0.56
0.05

© AKIpress News Agency - 2001-2015. All rights reserved
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75